Literature DB >> 26437283

Scleromyxedema secondary to hepatitis C virus and successfully treated with antiviral therapy.

J A Smith1, F A Kalimullah, C P Erickson, L S Peng.   

Abstract

Scleromyxedema (SM) is a chronic and progressive fibromucinous disease with no known etiology. We report a patient with scleromyxedema associated with hepatitis C virus, successfully treated with interferon and ribavirin therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26437283

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  2 in total

Review 1.  New insights on scleromyxedema.

Authors:  Laura Atzori; Caterina Ferreli; Franco Rongioletti
Journal:  J Scleroderma Relat Disord       Date:  2019-01-29

2.  A Case of Autoimmune Polyglandular Syndrome .ype 2 Associated with Atypical Form of Scleromyxedema.

Authors:  Oleksander Prylutskyi; Olga Prylutska; Anatoliy Degonskyi; Kseniia Tkachenko
Journal:  Ethiop J Health Sci       Date:  2016-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.